W Oigman
Overview
Explore the profile of W Oigman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Menezes V, Cohen C, Del-Rei J, Oigman W, Neves M, Medeiros F
Nutr Health
. 2019 Jan;
25(2):85-92.
PMID: 30614384
Background: Obesity is associated with metabolic imbalance, including insulin resistance and endothelial dysfunction. Aim: We aimed to evaluate clinical and vascular parameters in obese with or without insulin resistance. Methods:...
2.
Marques B, Trindade M, Aquino J, Cunha A, Gismondi R, Neves M, et al.
Clin Exp Hypertens
. 2018 Feb;
40(3):218-223.
PMID: 29431520
Endothelial dysfunction is a surrogate marker of cardiovascular risk. Resveratrol is known to improve endothelial function in animals, however, clinical trials are limited. We hypothesized that the acute trans-resveratrol supplementation...
3.
Malachias M, Neves M, Mion Junior D, Silva G, Lopes H, Oigman W
Arq Bras Cardiol
. 2016 Nov;
107(3 Suppl 3):18-24.
PMID: 27819383
No abstract available.
4.
Santos W, Matoso J, Maltez M, Goncalves T, Casanova M, Moreira I, et al.
J Hum Hypertens
. 2014 Dec;
29(8):488-94.
PMID: 25518896
Systolic hypertension is associated with cognitive decline in the elderly. Altered blood pressure (BP) variability is a possible mechanism of reduced cognitive performance in elderly hypertensives. We hypothesized that altered...
5.
Neldam S, Dahlof B, Oigman W, Schumacher H
Int J Clin Pract
. 2013 Aug;
67(9):843-52.
PMID: 23952464
Background: Rapid and sustained blood pressure (BP) goal attainment is important to reduce cardiovascular risk. Initial use of combination therapy may improve BP goal attainment. Methods: The Boehringer Ingelheim trial...
6.
Kasal D, Neves M, Oigman W, Mandarim-de-Lacerda C
Histol Histopathol
. 2008 Aug;
23(10):1241-8.
PMID: 18712676
It is widely recognized that L-NAME exposed rats develop myocardial fibrosis and hypertrophy. The aim of this study was to evaluate the contribution of xanthine oxidase (XO) to these phenomena...
7.
Madi J, Oigman W, Franco R, Armaganijan D
Int J Clin Pract
. 2001 Nov;
55(8):520-3.
PMID: 11695071
The objective of this study was to assess the efficacy and tolerability of valsartan (Diovan) when given alone or as part of a combination regimen in normal clinical practice, in...
8.
Ortega K, Santello J, Nobre F, Kohlman Junior O, Jardim P, da Costa L, et al.
Arq Bras Cardiol
. 2000 Aug;
74(3):283-90.
PMID: 10951830
Objective: To evaluate the anti-hypertensive effect of verapamil COER-24 180/240 mg in a single dose at bedtime as single therapy in mild to moderate hypertensives. Methods: A multicentric, open, placebo...
9.
Kohlmann Junior O, Jardim P, Oigman W
Arq Bras Cardiol
. 2000 Feb;
72(5):547-57.
PMID: 10668225
Objective: A double-blind, placebo-controlled multicenter study involving 34 centers from different Brazilian regions was performed to evaluate the antihypertensive efficacy and tolerability of trandolapril, an angiotensin I converting enzyme inhibitor,...
10.
Luna R, Oigman W, Ramirez J, Mion D, Batlouni M, DA ROCHA J, et al.
Arq Bras Cardiol
. 1999 May;
71(4):601-8.
PMID: 10347937
Purpose: Multicenter, open and non-controlled study to evaluated the efficacy and the tolerability of a low-dose combination of two anti-hypertensive agents: a cardioselective beta-blocker, bisoprolol (2.5 and 5.0 mg) with...